Orion’s CEO Liisa Hurme talked with Antti about the Q3 results and other recent topics 
Topics:
(00:00) Introduction
(00:11) ”An excellent quarter”
(00:23) Nubeqa behind the strong result
(01:25) Organizational change
(04:07) Manufacturing of Nubeqa’s active ingredient
(05:08) DASL-HiCaP study
(05:44) Significance of biosimilars
(07:23) Progress of ODM-216
(08:29) Long-term outlook